More Than Half Do Not Know Primary Care Providers Can Treat Opioid Use Disorder
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
FRIDAY, July 12, 2024 -- Many people do not know that a primary care provider (PCP) can provide medication for opioid use disorder (MOUD), according to a research letter published online June 28 in JAMA Network Open.
Brandon del Pozo, Ph.D., from the Brown University School of Public Health in Providence, Rhode Island, and colleagues surveyed 1,234 individuals to assess their awareness that MOUD can be prescribed by PCPs.
The researchers found that most respondents either did not know a PCP could treat people with an opioid use disorder by prescribing MOUD (61.4 percent weighted) or incorrectly believed a PCP could not (13.3 percent weighted). This was most true of Black respondents (20.9 percent weighted). Most respondents either agreed (53.9 percent) or strongly agreed (24.9 percent) that people should be able to receive OUD treatment in a PCP office. Among respondents who reported ever misusing prescription or illicit opioids, just over half (50.6 percent weighted) said they would be very comfortable and nearly a third (30.7 percent weighted) said they would be somewhat comfortable seeking MOUD from their PCP.
"Raising awareness that PCPs can [prescribe MOUD] is critical to increasing effective treatment of OUD and reducing the race-and-ethnicity-based disparities in knowledge about MOUD access observed in this study," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-13 01:15
Read more
- Half of Patients With Sepsis Die Within 2 Years, Hospital Study Finds
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- Celldex Announces Barzolvolimab Met All Primary and Secondary Endpoints with High Statistical Significance in Positive Phase 2 Study in Chronic Inducible Urticaria
- Prenatal Cannabis Exposure May Impact Executive Function, Behavior at Age 5 Years
- Lamotrigine, Mexiletine Show Similar Benefits for Nondystrophic Myotonias
- Orexo initiates new study of OX640 in participants with allergic rhiniti
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions